Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension

Hypertension. 2001 Dec 1;38(6):1337-41. doi: 10.1161/hy1201.096815.

Abstract

Epidermal growth factor (EGF) causes contraction in arteries from deoxycorticosterone acetate (DOCA)-salt hypertensive rats but not in normotensive sham rats. We hypothesized that an increase in the number of EGF receptors (EGFRs) in arteries from DOCA-salt rats enables the observed contraction to EGF to occur. DOCA-salt rats had a systolic blood pressure >170 mm Hg, whereas all sham rats had a systolic blood pressure <125 mm Hg. Thoracic aorta were removed for measurement of isometric force, EGFR mRNA levels, and EGFR protein levels. EGF caused a significant contraction in endothelium-denuded aorta from DOCA-salt rats (38+/-7% of maximal phenylephrine-induced [10 micromol/L] contraction) compared with aorta from sham rats (4+/-2%). The EGFR tyrosine kinase-specific inhibitors 4,5-dianilinophthalimide (10 micromol/L) and AG1478 (250 nmol/L) reduced contraction in aorta from DOCA-salt by 85+/-14% and 65+/-10%, respectively. EGFR mRNA in DOCA-salt aorta was increased 4.2-fold compared with that in sham aorta. However, Western analyses of membrane-enriched and whole-tissue lysate of aorta from sham and DOCA-salt revealed no statistical difference in the density of EGFR protein between sham and DOCA-salt aorta. These data refute our hypothesis and suggest that a change downstream of EGFR is responsible for enabling EGF-induced contraction in hypertension.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arteries / physiology*
  • Desoxycorticosterone
  • Dose-Response Relationship, Drug
  • ErbB Receptors / administration & dosage
  • ErbB Receptors / physiology*
  • Hypertension / chemically induced
  • Hypertension / physiopathology*
  • In Vitro Techniques
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Sodium, Dietary / administration & dosage*
  • Vasomotor System / drug effects
  • Vasomotor System / physiology*

Substances

  • Sodium, Dietary
  • Desoxycorticosterone
  • ErbB Receptors